BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 10091734)

  • 21. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 22. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Samuel S; Kapelushnik J; Brautbar C; Or R
    Blood; 1996 Mar; 87(6):2195-204. PubMed ID: 8630379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
    Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Mar; 42(3):204-8. PubMed ID: 11345783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia.
    Au WY; Chan AC; Lie AK; Chen FE; Liang R; Kwong YL
    Bone Marrow Transplant; 1998 Jan; 21(2):205-8. PubMed ID: 9489639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
    Ocheni S; Iwanski GB; Schafhausen P; Zander AR; Ayuk F; Klyuchnikov E; Zabelina T; Fiedler W; Schnittger S; Hochhaus A; Brümmendorf TH; Kröger N; Bacher U
    Leuk Lymphoma; 2009 Apr; 50(4):551-8. PubMed ID: 19373652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis.
    Frassoni F; Podestà M; Piaggio G; Pitto A; Figari O; Soracco M; Lint M; Fugazza G; Sessarego M; Bacigalupo A
    Bone Marrow Transplant; 1999 Sep; 24(6):689-91. PubMed ID: 10490738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
    Michel G; Boulad F; Small TN; Black P; Heller G; Castro-Malaspina H; Childs BH; Gillio AP; Papadopoulos EB; Young JW; Kernan NA; O'Reilly RJ
    Bone Marrow Transplant; 1997 Jul; 20(2):107-12. PubMed ID: 9244412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engraftment following mitoxantrone (Mito) based conditioning for allogeneic bone marrow transplantation (allo-BMT).
    Nagler A; Soni S; Samuel S; Or R
    Leuk Res; 1998 Mar; 22(3):209-13. PubMed ID: 9619912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.
    Békássy AN; Hermans J; Gorin NC; Gratwohl A
    Bone Marrow Transplant; 1996 May; 17(5):801-8. PubMed ID: 8733701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
    Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
    Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
    Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
    J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
    Bär BM; Schattenberg A; Mensink EJ; Geurts Van Kessel A; Smetsers TF; Knops GH; Linders EH; De Witte T
    J Clin Oncol; 1993 Mar; 11(3):513-9. PubMed ID: 8445426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extramedullary relapse of chronic myeloid leukemia in blast crisis: more questions than answers.
    Ross DM
    Leuk Lymphoma; 2009 Apr; 50(4):517-8. PubMed ID: 19373644
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V; Zoccolante A; Bosi A; Guidi S; Saccardi R; Vannucchi AM; Martinazzo G; Bernabei PA; Ferrini PR
    Haematologica; 1996; 81(3):201-7. PubMed ID: 8767524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.